TGFB1 and neoplasm: Tumors of mice that received Reo&CD3-bsAbs as well as TGF-β blockade did not regress in size after receiving CD3-bsAbs but displayed similar tumor growth as observed in mice treated with TGF-β blockade alone (Fig. 5C and D).